Fair Value of Financial Assets and Liabilities Fair Value Disclosures [Text Block] Prepaid Expenses and Other Assets Other Current Assets [Text Block] Prepaid Expenses and Other Assets [Abstract] Stockholders’ Equity Shareholders' Equity and Share-Based Payments [Text Block] Stockholders’ Equity [Abstract] Schedule Of Estimated Using The Black Scholes Option Pricing Model Abstract Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Number of Warrants, Outstanding ending balance Number of Warrants, Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Warrant Activity [Member] Warrants [Member] Warrant [Member] Warrant [Member] Expected stock price volatility [Member] Measurement Input, Option Volatility [Member] Term (years) [Member] Measurement Input, Expected Term [Member] Exercise price [Member] Measurement Input, Exercise Price [Member] Fair Value Measurement Inputs and Valuation Techniques [Table] Schedule of Estimated Using the Black-Scholes Option-Pricing Model [Line Items] Class of Warrant or Right [Axis] Weighted Average Exercise Price, Warrants exercisable Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercisable Weighted Average Exercise Price Represent the weighted average exercise price, warrants exercisable. Number of Warrants, Warrants exercisable Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercisable Number Represent the warrants exercisable. Total Intrinsic Value, Warrants exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Exercisable Intrinsic Value1 Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of warrants outstanding and currently exercisable. Weighted Average Exercise Price, Expired Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Expired Weighted average exercise price, expired. Weighted Average Exercise Price, Outstanding balance Weighted Average Exercise Price, Outstanding ending balance Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Represent the weighted average exercise price, Outstanding. Schedule of Warrant Activity [Line Items] Weighted Average Remaining Contractual Life (in years), Outstanding balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Class of Warrant or Right [Table] Class of Warrant or Right [Domain] Total Intrinsic Value, Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonGrantedEquityInstrumentsForfeituresIntrinsicValue Amount of share based compensation arrangement by share based payment award non granted equity instruments forfeitures intrinsic value. Weighted Average Remaining Contractual Life (in years), Granted Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Granted Weighted average remaining contractual term for option awards outstanding granted Number of Warrants, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Weighted Average Exercise Price, Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Total Intrinsic Value, Expired Share Based Compensation Arrangement By Share Based Payment Award Non Expired Equity Instruments Forfeitures Intrinsic Value Represent the intrinsic value, expired. Weighted Average Remaining Contractual Life (in years), Warrants exercisable Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms Weighted average remaining contractual life (in years), other than options exercisable. Schedule Of Warrant Activity Abstract Black-Scholes option-pricing model Warrants and Rights Outstanding, Measurement Input Measurement Input Type [Domain] Measurement Input Type [Axis] Risk-free rate of interest [Member] Measurement Input, Risk Free Interest Rate [Member] Term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Exercise price (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price Subsequent Events Subsequent Events [Text Block] Schedule of Black-Scholes Option-pricing Model Assumptions [Abstract] Scenario [Domain] Foreign cost term Foreign Cost Term Foreign cost term. Limited Partnership [Member] Limited Partnership Member Summary of Significant Accounting Policies (Details) [Table] Exercise price of warrants Exercise price per warrant (in Dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Common Stock [Member] Common Stock [Member] Common Stock Equity Component [Domain] Other offering expenses Other Expenses Schedule of Research and Development Expenses for License, Patents, Software and Other Technologies Agreements Schedule Of Research And Development Expenses For Licenses And Patent Applications Acquired Table Text Block Tabular disclosure of research and development expenses for licenses and patent applications acquired Schedule of Intangible Assets [Abstract] Schedule of Level 3 Financial Assets are Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value of Financial Assets and Liabilities [Abstract] Schedule of Prepaid Expenses and Other Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of Estimated Using the Black-Scholes Option-Pricing Model Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Activity [Table Text Block] Schedule of Stock Options Outstanding Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Schedule of Black-Scholes Option-pricing Model Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Commitments and Contingencies [Abstract] Schedule of Lease Costs, Which are Included in General and Administrative Expenses Lease, Cost [Table Text Block] ATM Agreement [Member] ATMAgreement Member Working capital Working Capital Amount of working capital. Forecast [Member] Summary of Significant Accounting Policies [Line Items] Crypto assets Crypto assets, at fair value Fair Value, Ending Balance Fair Value, Beginning Balance Crypto Asset, Fair Value, Current Limited partnership, percentage Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest Schedule of Condensed Consolidated Balance Sheet Crypto Asset, Holding [Table Text Block] Schedule of Assets and Liabilities that are Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Warrant Activity Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Digital Assets, at Fair Value Digital Assets, at Fair Value [Policy Text Block] Disclosure of accounting policy for digital assets at fair value. Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Organization and Description of Business Operations (Details) [Table] Weighted average price per share weighted average price per share Number of share weighted average price. Cash and cash equivalents Cash and Cash Equivalent Aggregate warrants Class of Warrant or Right, Outstanding Net cash used in operating activities NET CASH USED IN OPERATING ACTIVITIES Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total Net loss NET LOSS Going Concern Considerations [Member] Schedule of Anti-Dilutive Impact on the Company’s Net Loss [Abstract] Earnings Per Share, Diluted, Other Disclosure [Abstract] Antidilutive Security, Excluded EPS Calculation [Table] Options [Member] Equity Option [Member] BTC (Bitcoin) [Member] BTCBitcoin Member Leases Lessee, Leases [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Summary of Significant Accounting Policies [Abstract] Preferred stock, shares authorized Preferred stock, shares authorized (in Shares) Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued North Carolina State University [Member] North Carolina State University Member Patent Application Acquisition Agreement [Member] Patent Application Acquisition Agreement Member License fees Research and development expense Research And Development Expenses For Licenses And Patent Represents the amount of research and development expenses for licenses and patent. The George Washington University [Member] The George Washington University Member U.S. Department of Veterans Affairs [Member] U.S. Department of Veteran Affairs [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Common shares value (in Dollars) Common stock, $0.0001 par value; 50,000,000 shares authorized; 23,184,634 and 15,514,312 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Stock-based compensation expense (in Dollars) Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Stock Options [Member] Stock-based professional fees (in Dollars) Operating Lease, Right-of-Use Asset, Periodic Reduction Virginia Commonwealth University [Member] University of Cincinnati [Member] University Of Cincinnati Member Prepaid stock-based compensation The amount of prepaid stock-based compensation. Purchase price purchase price. H.C. Wainwright & Co., LLC [Member] HCWainwright Co LLCMember Net proceeds Net proceeds Amount of net proceeds. Drone cluster technologies Drone cluster technologies Research and development expense Research and Development Expense, Total Patent applications, software and other technologies acquired [Member] Segment Reporting [Abstract] Segment Reporting Segment Reporting [Text Block] Schedule of Reportable Business Segments Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block] Schedule of Total Assets by Segment Segment Reporting, Reconciliation of Asset by Segment to Consolidated [Table Text Block] Number of Operating Segments Description of segment Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Warrant expiration date Warrants and Rights Outstanding, Maturity Date Monthly base rent Payments for Rent Issuance of common stock Common shares issued Common stock issued for cash, net (in Shares) Stock Issued During Period, Shares, New Issues Weighted Average Exercise Price, Expired Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years), Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Exercise Price, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Number of Shares, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Total Intrinsic Value, Options vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Weighted Average Remaining Contractual Life (in years), Outstanding ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Class of Stock [Domain] Class B Common Stock [Member] Common Class B [Member] Fair Value of Financial Assets and Liabilities [Line Items] Schedule Of Level3 Financial Assets Are Measured At Fair Value On ARecurring Basis Abstract Number of share sold Sale of Stock, Number of Shares Issued in Transaction Collaborative Arrangement and Arrangement Other than Collaborative [Axis] License and Patent Agreements - Schedule of Research and Development Expenses for Licenses and Patents Acquired (Details) [Table] License Agreements and Acquired Patent Applications - Schedule of Research and Development Expenses for Licenses and Patent Applications Acquired (Details) [Table] Schedule of Research and Development Expenses for Licenses and Patents Acquired [Abstract] Schedule of Research and Development Expenses for Licenses and Patents Acquired [Line Items] Schedule of Research and Development Expenses for Licenses and Patent Applications Acquired [Line Items] Related and Nonrelated Parties [Domain] Common stock outstanding percentage Common stock outstanding percentage Percentage of common stock outstanding. Exercise price Purchase price Sale of Stock, Price Per Share Offering expenses paid Offering expenses paid. Prepaid expenses Other Prepaid Expense, Current April 2026 Warrants [Member] Investment in shares (in Shares) Investment Owned, Balance, Shares Consolidated investment Investment in joint ventures Investment in joint ventures at fair value – end of period Investment in joint ventures at fair value – beginning of period Investment in joint ventures at fair value Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Price per share (in Dollars per share) Shares Issued, Price Per Share Class of Stock [Axis] Reverse stock split Stockholders' Equity, Reverse Stock Split Fair Value of Financial Assets and Liabilities - Schedule of Assets and Liabilities that are Measured at Fair Value (Details) [Table] Schedule Of Assets And Liabilities That Are Measured At Fair Value Abstract Schedule of Assets and Liabilities that are Measured at Fair Value [Line Items] Fair Value Hierarchy and NAV [Axis] Quoted prices in active markets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant other observable inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Significant unobservable inputs (Level 3) [Member] Level 3 Financial Assets [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Hierarchy and NAV [Domain] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses [Line Items] Schedule of Stock Based Compensation Expense [Line Items] Short-term lease expense Short-Term Lease, Cost Total ROU asset, net Operating lease right-of-use asset, net Operating Lease, Right-of-Use Asset Operating cash flows for operating leases Operating Lease, Payments Related Party Transaction [Axis] Related Party Transaction [Domain] Related and Nonrelated Parties [Axis] License and Patent Agreements [Line Items] License Agreements and Acquired Patent Applications [Line Items] Percentage of commission Percentage Of Commission Gross Proceeds From Sales Of Shares Represent the percentage of commission gross proceeds from sales of shares. Units Held Crypto Asset Units Held Number of restricted and unrestricted crypto asset units held. Excludes crypto asset units held for platform user. ETH (Ethereum) [Member] ETHEthereum Member Schedule of Condensed Consolidated Balance Sheet [Abstract] SOL (Solana) [Member] SOLSolana Member Crypto Asset [Axis] Crypto Asset [Domain] Cost Basis Crypto Asset, Cost Schedule of Condensed Consolidated Balance Sheet [Line Items] Schedule of Consolidated Balance Sheet [Line Items] Crypto Asset, Holding [Table] Crypto Assets, at Fair Value [Abstract] Realized loss on crypto assets Realized loss on crypto assets Crypto Asset, Realized Loss, Operating Common Stock Warrants [Member] Common Stock Warrants Member January 2023 Existing Warrants [Member] January Two Thousand And Twenty Three Existing Warrants Member Schedule of Reportable Business Segments [Abstract] Segment Reporting [Table] Segment Reporting [Line Items] Net revenues NET REVENUES Revenues, Total Operating expenses Total operating expenses Operating Expenses, Total Depreciation and amortization Depreciation, Total Loss from operations LOSS FROM OPERATIONS Operating Income (Loss), Total Other income Other Nonoperating Income Interest expense Interest Expense, Nonoperating, Total Provision for income taxes Income Tax Expense (Benefit) Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total Schedule of Total Assets by Segment [Abstract] Total assets by segment Total Assets Assets, Total Patent Applications, Software and Other Technologies [Member] Number of Reportable Segments Not Disclosed Flag Represent the number of reportable segments not disclosed flag. Segments [Axis] Segments [Domain] Biopharmaceutical Segment [Member] AI Infrastructure and Technologies segment [Member] Aggregate market value Aggregate market value. Aggregate sales price Proceeds from issuance of common stock, net of offering costs Net proceeds from common stock Amount of initial investment Amount of initial investment. Discount rate Percentage represents discount rate. Aggregate share issued ATM agreement Aggregate share issued ATM agreement. Number of shares, Outstanding beginning balance Number of Shares, Outstanding ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance Weighted average exercise price, Outstanding beginning balance Weighted Average Exercise Price, Outstanding ending Stock option exercise price (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance Total Intrinsic value, Outstanding beginning balance Total Intrinsic Value, Outstanding ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value $14.75 to $76.25 [Member] Fourteen Point Seven Five To Seventy Six Point Two Five Member Above $76.25 [Member] Above Seventy Six Point Two Five Member Stock-based compensation expense Stock based compensation expense Share-Based Payment Arrangement, Expense Schedule of Stock-Based Compensation Expense Included Within Research and Development and General and Administrative Expenses Abstract Research and development [Member] Professional fees [Member] Professional Fees Member Income Statement Location Balance [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Subsequent Events [Abstract] Subsequent Event [Member] Subsequent Event [Member] Subsequent Events [Line Item] Entity Registrant Name Entity Shell Company Entity Small Business Entity Tax Identification Number Entity Interactive Data Current Local Phone Number Title of 12(b) Security Security Exchange Name Trading Symbol Interest income Investment Income, Interest Common stock and warrants issued for cash, net Stock Issued During Period Value Common stock and warrants issued for cash, net Amount of common stock and warrants issued for cash, net. Common stock and warrants issued for cash, net (in Shares) Stock Issued During Period SharesCommon stock and warrants issued for cash, net Number of common stock and warrants issued for cash, net. Issuance of common stock for professional fees Stock Issued During Period, Value, Other Issuance of common stock for professional fees (in Shares) Stock Issued During Period, Shares, Other Issuance of warrants for professional fees Adjustments to Additional Paid in Capital, Warrant Issued Proceeds from issuance of common stock and warrants, net of offering costs The cash inflow from issuance of common stock and warrants, net of offering costs. Stock-based professional fees Professional Fees NON-CASH INVESTING AND FINANCING ACTIVITIES: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Common stock issued for future services Stock Issued Document Information [Line Items] Document Fiscal Period Focus Reclassification of deferred offering costs to additional paid-in capital Reclassification of deferred offering costs to additional paid-in capital. Common shares issued for exercise of warrants Stock Issued During Period Value Warrants Exercised Value of warrants issued as a result of the exercise of warrants. Additional Paid-in Capital Additional Paid-in Capital [Member] Statement [Table] Total Current Liabilities Liabilities, Current Total other income (expenses), net Nonoperating Income (Expense) CURRENT LIABILITIES: Liabilities, Current [Abstract] Operating lease liability, current portion Current portion of operating lease liability Operating Lease, Liability, Current Common stock issued for patent (in Shares) Stock Issued During Period Shares Common Stock Issued For Patent Number of common stock issued for patent. Research and development-acquired patent, expensed Amount of research and development-acquired patent, expensed. NET CASH PROVIDED BY INVESTING ACTIVITIES Cash Provided by (Used in) Investing Activity, Including Discontinued Operation NET INCREASE IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation STOCKHOLDERS’ EQUITY: Equity, Attributable to Parent [Abstract] Preferred stock, shares designated (in Shares) Preferred stock, shares designated Preferred Stock Shares Designated Preferred stock, shares designated. Other comprehensive income (loss): Other Comprehensive Income (Loss), Tax [Abstract] Diluted Weighted Average Number of Shares Outstanding, Diluted Statement [Line Items] Statement of Financial Position [Abstract] Common stock, par value (in Dollars per share) Common Stock, Par or Stated Value Per Share WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: Weighted Average Number of Shares Outstanding, Basic [Abstract] Diluted Earnings Per Share, Diluted Basic Earnings Per Share, Basic COMPREHENSIVE LOSS: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accumulated other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Balance (in Shares) Balance (in Shares) Shares, Outstanding Proceeds from exercise of warrants Proceeds from Warrant Exercises CASH FLOWS FROM OPERATING ACTIVITIES: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Accrued expenses Accrued Liabilities, Current Accounts payable Accounts Payable, Current Preferred stock, value Preferred Stock, Value, Issued Total Intrinsic Value, Outstanding balance Total Intrinsic Value, Outstanding ending balance Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Intrinsic Value Represent the amount of intrinsic value, outstanding. Number of Warrants, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Expected stock price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free rate of interest Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Scenario [Axis] Organization and Description of Business Operations [Line Items] Stockholders’ Equity [Line Items] Warrants Warrants Policy Text Block Disclosure of accounting policy for its Warrants. Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Concentrations of Credit Risk and Off-Balance Sheet Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Basis of Presentation and Principles of Consolidation Consolidation, Policy [Policy Text Block] Segment Reporting Segment Reporting, Policy [Policy Text Block] Ownership [Axis] Ownership [Domain] Bank accounts and highly liquid money funds Cash Equivalents, at Carrying Value Federally insured amount Cash, FDIC Insured Amount Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Investment in Joint Ventures Investment, Policy [Policy Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Schedule of Anti-Dilutive Impact on the Company’s Net Loss Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Reconciliation of Crypto Assets Crypto Asset, Activity [Table Text Block] Organization and Description of Business Operations [Abstract] Offering gross proceeds Proceeds from Issuance Initial Public Offering Gross proceeds Proceeds from Issuance of Private Placement Accumulated deficit Retained Earnings (Accumulated Deficit) Equity Components [Axis] Total anti-dilutive Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities [Axis] Schedule of Anti-Dilutive Impact on the Company’s Net Loss [Line Items] Antidilutive Securities, Name [Domain] Cash held in foreign bank Cash and Cash Equivalent, Held in Foreign Currency Capitalized amortized term Capitalized Amortized Term Capitalized amortized term. Amortize term Amortize Term Amortize term. Long-term portion of operating lease liability Operating Lease, Liability, Noncurrent Exercise of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Crypto units sold, at fair value Crypto Asset, Unrealized Gain (Loss), Nonoperating License Agreements and Acquired Patent Applications (Details) [Table] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Estimated warrants Cash proceeds of warrants Proceeds from Issuance of Warrants Exercise Price Range [Axis] Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Up to $2.59 [Member] Up To Two Point Five Nine Member Schedule Of Stock Options Outstanding Abstract Schedule of Option Activity [Abstract] Number of Shares, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Total Intrinsic Value, Expired Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value Expired Represents the amount of total of intrinsic value, expire. Change in fair value of investment in joint ventures Change In Fair Value Of Investment In Joint Venture Represent the amount of change in fair value of investment in joint venture. Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair Value, Recurring [Member] Cash payment (in Dollars) Payments to Acquire Intangible Assets Plan Name [Axis] Plan Name [Domain] Preferred Stock [Member] Preferred Stock [Member] Preferred stock, par value (in Dollars per share) Preferred Stock, Par or Stated Value Per Share Lease term Lessee, Operating Lease, Term of Contract Non-employee restricted stock awards [Member] Non Employee Restricted Stock Awards Member Employee stock option awards [Member] Employee Stock Option Awards Member Options outstanding and exercisable, Weighted Average Remaining Contractual Life (in years) Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term Options outstanding and exercisable, Weighted Average Exercise Price Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price Options outstanding and exercisable, Number of Shares Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding Schedule of Stock Options Outstanding by Price Range [Line Items] Schedule of Prepaid Expenses and Other Assets [Abstract] Prepaid expenses and other assets, current portion Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Prepaid expenses and other assets, long-term portion Prepaid expenses and other assets, net of current portion Prepaid Expense and Other Assets, Noncurrent Prepaid insurance Prepaid Insurance Aggregate grant date fair value of options (in Dollars) Aggregate Grant Date Fair Value Of Options Represents the amount of aggregate grant date fair value of options. April 2024 Inducement Warrants [Member] April Two Thousand Twenty Four Inducement Warrants Member Series A Convertible Preferred Stock Series A Convertible Preferred Stock Series A Preferred Stock [Member] Series B Preferred Stock [Member] Series B Preferred Stock Series B Preferred Stock [Member] Common stock available for grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Other prepaid expenses Other Prepaid Expense Represents the amount of other prepaid expenses. Prepaid clinical trial expenses Prepaid Clinical Trial Expenses The amount of prepaid clinical trial expenses. R&D credit receivable Research Developmen Credit Receivable The amount of research and development credit receivable. Total Prepaid Expense and Other Assets April Placement Agent Warrants [Member] VA Agreement [Member] VCU License Agreement [Member] Exercisable exercise price per share Exercise Price Per Share Exercise price per share. Number of Shares, Employee options issued Share based compensation arrangement by share based payment award options employee options issued Share based compensation arrangement by share based payment award options employee options issued Weighted Average Exercise Price, Employee options issued Share based compensation arrangements by share based payment award options Employee options issued period weighted average exercise price Share based compensation arrangements by share based payment award options Employee options issued period weighted average exercise price. Total Intrinsic Value, Employee options issued Share based compensation arrangement by share based payment award options Employee options issued Intrinsic Value Share based compensation arrangement by share based payment award options Employee options issued Intrinsic Value Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Measurement Frequency [Axis] Schedule of Level 3 Financial Assets are Measured at Fair Value on a Recurring Basis [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Class C Common Share [Member] Class N common stock [Member] Fair Value of Financial Assets and Liabilities (Details) [Table] Percentage of voting rights Percentage of voting rights Zylö Therapeutics [Member] Zyl Therapeutics Member Preferred stock, shares undesignated Preferred stock, shares undesignated (in Shares) Preferred Stock Shares Undesignated Preferred stock, shares undesignated. Stockholders’ Equity (Details) [Table] 2018 Equity Incentive Plan [Member] Two Thousand Eighteen Equity Incentive Plan Member 2022 Equity Incentive Plan [Member] Two Thousand Twenty Two Equity Incentive Plan Member Unregistered warrants to purchase shares Unregistered Warrants To Purchase Shares Number of unregistered warrants to purchase shares. Board of Directors [Member] Board of Directors Chairman [Member] Title and Position [Axis] Title and Position [Domain] Warrants issued Class of Warrant or Right, Number of Securities Called by Warrants or Rights Shares reserved Common Stock, Capital Shares Reserved for Future Issuance Subsequent Events (Details) [Table] Current offering price Current Offering Price Amount of current offering. Investment, Issuer Name [Axis] Investment, Issuer Name [Domain] Investment share amount Investment Owned, Balance, Principal Amount Stockholders’ Equity - Schedule of Stock-Based Compensation Expense (Details) [Table] Schedule Of Stock Based Compensation Expense Abstract Non-employee stock warrant awards [Member] Nonemployee Stock Warrant Awards Member Total operating lease liability Operating Lease, Liability Operating lease expense Operating Lease, Cost Cash paid for amounts included in the measurement of lease liabilities: Leases [Abstract] Schedule of Lease Cost, Right-of-Use Asset, Operating Lease Liability and Supplemental Cash Flow Information Related to Leases [Abstract] Total lease cost Lease, Cost Office lease ROU asset Office Lease Rightofuse Asset Gross Represents the amount of office lease right-of-use asset, gross portion. Less accumulated amortization Accumulated Amortization Right Of Use Asset Represents the amount of accumulated amortization of right of use asset. Classification Crypto Assets Classification Number of crypto assets classification. Income Statement Location Balance [Axis] General And Administrative [Member] Options issued to purchase shares Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Share price (in Dollars per share) Share Price Exercise Price Range [Domain] Deferred offering costs Deferred Offering Costs NET LOSS PER COMMON SHARE: Earnings Per Share [Abstract] Proceeds from sale of crypto assets Proceeds from Disposal, Crypto Asset CASH FLOWS FROM INVESTING ACTIVITIES: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] NET CASH PROVIDED BY FINANCING ACTIVITIES Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Lease costs Gain (Loss) on Termination of Lease Total Current Assets Assets, Current CURRENT ASSETS: Assets, Current [Abstract] Total Non-Current Assets Assets, Noncurrent Common shares issued for exercise of warrants (in Shares) Stock Issued During Period Shares Warrants Exercised Number of warrants (or share units) exercised during the current period. Common stock, shares outstanding (in Shares) Common Stock, Shares, Outstanding Document Information [Table] Document Period End Date Document Quarterly Report Document Transition Report Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Document Fiscal Year Focus Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Emerging Growth Company Entity File Number Entity Filer Category Entity Incorporation, State or Country Code Entity Address, State or Province Current Fiscal Year End Date Cover [Abstract] City Area Code Amendment Flag Commitments and Contingencies (Note 8) Commitments and Contingencies NON-CURRENT ASSETS: Assets, Noncurrent [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Common stock issued for cash, net Stock Issued During Period, Value, New Issues Total Liabilities and Stockholders’ Equity Liabilities and Equity Total Liabilities Liabilities Balance Balance Total Stockholders’ Equity Equity, Attributable to Parent Statement of Stockholders' Equity [Abstract] Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated Deficit Retained Earnings [Member] Cumulative translation adjustment Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) Organization and Description of Business Operations Business Description and Basis of Presentation [Text Block] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Income Statement [Abstract] General and administrative expenses General and Administrative Expense OTHER INCOME (EXPENSES), NET: Nonoperating Income (Expense) [Abstract] OPERATING COSTS AND EXPENSES: Operating Costs and Expenses [Abstract] Common stock issued for patent Stock Issued During Period Value Common Stock Issued For Patent Value of common stock issued for patent. Prepaid expenses Increase (Decrease) in Prepaid Expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Statement of Cash Flows [Abstract] Common stock, shares authorized (in Shares) Common Stock, Shares Authorized Common stock, shares issued (in Shares) Common Stock, Shares, Issued Basic Weighted Average Number of Shares Outstanding, Basic Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] CASH AND CASH EQUIVALENTS - end of period CASH AND CASH EQUIVALENTS - beginning of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Entity Address, Postal Zip Code Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Crypto Assets, at Fair Value Crypto Asset [Text Block] License and Patent Agreements License Agreements [Text Block] The entire disclosure of license agreements and acquired patent applications. Chief Executive Officer